Sessa Capital (Master), L.P.

Insider Reports History

Entity
Company
Location
888 Seventh Avenue, 30 Th Floor, New York, NY
Signature
/s/ John Petry, for Sessa Capital (Master), L.P., By: Sessa Capital GP, LLC, its general partner, By: John Petry, as manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sessa Capital (Master), L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. Director Series A-2 Convertible Preferred Stock 28.4K $28.4M $1,000.00 Nov 24, 2023 Direct
SAB Biotherapeutics, Inc. Director Common Stock 4.58M $4.03M $0.88 Nov 24, 2023 Direct
SAB Biotherapeutics, Inc. Director Tranche C Warrants 52.1K Nov 10, 2023 Direct
SAB Biotherapeutics, Inc. Director Tranche B Warrants 20.8K Nov 10, 2023 Direct
Provention Bio, Inc. 10%+ Owner Common Stock 0 $24.32 Apr 27, 2023 Direct
SAB Biotherapeutics, Inc. Director Series A-1 Convertible Preferred Stock 0 $1,000.00 Nov 24, 2023 Direct
SAB Biotherapeutics, Inc. Director Tranche A Warrants 0 Nov 13, 2023 Direct

Insider Reports Filed by Sessa Capital (Master), L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SABS SAB Biotherapeutics, Inc. Nov 24, 2023 3 -$2.89M 4 Nov 28, 2023 Director
SABS SAB Biotherapeutics, Inc. Nov 10, 2023 1 $13.3M 4/A Nov 15, 2023 Director
SABS SAB Biotherapeutics, Inc. Oct 23, 2023 2 $16.3M 4 Oct 24, 2023 Director
SABS SAB Biotherapeutics, Inc. Oct 2, 2023 0 $0 3 Oct 10, 2023 Director
PRVB Provention Bio, Inc. Apr 27, 2023 1 $0 4 Apr 28, 2023 10%+ Owner
PRVB Provention Bio, Inc. Apr 20, 2023 2 $0 4 Apr 24, 2023 10%+ Owner
PRVB Provention Bio, Inc. Apr 14, 2023 3 -$14 4 Apr 18, 2023 10%+ Owner
PRVB Provention Bio, Inc. Mar 31, 2023 2 $0 4 Apr 4, 2023 10%+ Owner
PRVB Provention Bio, Inc. Jan 18, 2023 1 -$28.2M 4 Jan 20, 2023 10%+ Owner
PRVB Provention Bio, Inc. Jul 7, 2022 0 $0 3 Jul 11, 2022 10%+ Owner